Search results for " Cytiva"
Article
Taking a “Development-by-Design” Approach to Cell Therapies
Jun 15, 2015
By Agnes Shanley
BioPharm International eBooks
Volume 28, Issue 13
Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, c…
Article
A Bright Future for the Plasma Fractionation Industry
There is still a very bright future for the plasma fractionation industry. That was one of the conclusions reached when the 9th Plasma Product Biotechnology (PPB) meeting ended on the beautiful isla…
Article
Optimizing KiH bispecific antibody chromatography steps
This web article describes how Bioprocessing Technology Institute (BTI), Singapore together with scientists at Cytiva developed an optimized capture step for two closely related knob-into-hole (KiH) b…
Article
Introducing the VH3 ligand ELISA kit
Our new VH3 ligand ELISA kit - the latest addition to Cytiva’s impurity portfolio - is the only commercial solution dedicated to testing VH3 ligand leakage. This kit is essential for users of MabSelec…
Article
You are invited to attend DiPIA 2024
DiPIA, or Developments in Protein Interaction Analysis, is a global scientific conference hosted by Cytiva. We bring peers together from across the industry to share best practices, research, and new …
Article
Impurity ELISA automation for faster process development
This blog highlights how Cytiva impurity ELISA kits are easily integrated into automated systems such as the Biomek i5 to increase throughput, while maintaining the same robust and sensitive results y…
Article
Register to the Chromatography + Filtration Virtual Summit 2024
Explore the latest advancements in process development and scale-up
5-7 March, 2024 - 15:00 - 18:00 CET all 3 days
Join Cytiva Chromatography and filtration summit online to lear…
Article
Chromatography innovations for the diversified antibody pipeline
Introducing MabSelect™ VH3 affinity resin for antibody variants
At Cytiva, we connect with process developers and manufacturers to understand their needs and strive to make t…
Article
Dear lentivirus: We have not forgotten about you and how to improve your polishing recovery
Lentiviruses are commonly used for both chimeric antigen receptor (CAR) T cell therapy and ex vivo gene therapy.
Vector purification is very challenging due to low stability of these envel…
Article
Process Development for Viral Vectors
Scaling viral vector processes can be challenging, but it doesn't have to slow you down. Cytiva can help you own your process and gain valuable expertise. Download a case study from Fast Trak™…